on Cantourage Group SE (isin : DE000A3DSV01)
First Berlin Reiterates Buy Rating for Cantourage Group SE
First Berlin Equity Research GmbH has released an update on Cantourage Group SE, maintaining its "Buy" recommendation with a target price of €10.50. The focus of this update is Boots, a major UK pharmacy chain. Boots announced its entry into the UK's medical cannabis market with a nationwide online prescribing service. The entrance of a reputable name like Boots is expected to positively impact the acceptance of medical cannabis in Britain.
The potential market expansion could normalize cannabis as a treatment option, attracting more patients and facilitating regulatory changes in the future. This strategic move may have significant implications despite challenges like stigma. Cantourage's price target suggests a potential 126% upside, affirming confidence in the company's future prospects.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Cantourage Group SE news